Core Labs (CLB +8%) is upgraded to Outperform with a $150 target price, up from $110, at FBR...

|About: Core Laboratories (CLB)|By:, SA News Editor

Core Labs (CLB +8%) is upgraded to Outperform with a $150 target price, up from $110, at FBR Capital after a "very strong" Q4 and outlook. The firm thinks CLB should benefit from continued beat-and-raise quarters and upward Street earnings revisions in 2013. Given CLB's attractive niche, "investors looking for a pullback before getting more involved in the stock could miss the boat all together."